ASCL3 and metabolic dysfunction-associated steatotic liver disease: We also identified that ACSL3 was aberrantly expressed among genes linked to fatty acid metabolic pathways in NAFLD (Figure 1B), and ASCL3 mRNA levels were upregulated in NASH (Figure 1C).